Cutiss, DenovoSkin Changing the Standard of Burn Care Across the Globe
CEO Daniela Marino, PhD, emphasizes that the Switzlerand based company has received Orphan Drug Designation from the Swissmedic, EMA, and FDA, for its personalized human skin graft.